An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Recruiting now

Conditions studied: Pulmonary Hypertension, Interstitial Lung Disease

In brief

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

Key facts

Study ID
NCT06129240
Run by
Liquidia Technologies, Inc.
People needed
80
Starts
2023-12-28
Expected to finish
2028-02-08
Last updated by the study team
2026-06-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.